Why is AroCell AB ?
- ROCE(HY) Highest at -14.12%
- RAW MATERIAL COST(Y) Fallen by -24.11% (YoY)
- NET SALES(Q) Highest at SEK 16.74 MM
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -26.25%, its profits have risen by 26.1%
- Along with generating -26.25% returns in the last 1 year, the stock has also underperformed OMX Stockholm 30 in each of the last 3 annual periods
How much should you hold?
- Overall Portfolio exposure to AroCell AB should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at -14.12%
Fallen by -24.11% (YoY
Highest at SEK 16.74 MM
Highest at SEK 1.07 MM
Highest at 6.41 %
Highest at SEK 1.21 MM
Highest at SEK 1.21 MM
Highest at SEK 0.01
At SEK -3.34 MM has Grown at -85.6%
At SEK 0.22 MM has Grown at 85.71%
Lowest at SEK 73.91 MM
Lowest at 4.17 times
Here's what is working for AroCell AB
Pre-Tax Profit (SEK MM)
Net Profit (SEK MM)
Net Sales (SEK MM)
Net Sales (SEK MM)
Operating Profit (SEK MM)
Operating Profit to Sales
Pre-Tax Profit (SEK MM)
Net Profit (SEK MM)
EPS (SEK)
Raw Material Cost as a percentage of Sales
Here's what is not working for AroCell AB
Interest Paid (SEK MM)
Cash and Cash Equivalents
Inventory Turnover Ratio






